Compare CLDX & XZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLDX | XZO |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 1995 | N/A |
| Metric | CLDX | XZO |
|---|---|---|
| Price | $29.61 | $13.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $46.60 | $27.00 |
| AVG Volume (30 Days) | ★ 644.2K | 184.6K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,743,000.00 | N/A |
| Revenue This Year | $111.39 | $9.11 |
| Revenue Next Year | $235.85 | $16.05 |
| P/E Ratio | ★ N/A | $18.63 |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $18.56 | $12.92 |
| 52 Week High | $35.83 | $24.60 |
| Indicator | CLDX | XZO |
|---|---|---|
| Relative Strength Index (RSI) | 35.30 | 39.59 |
| Support Level | $28.30 | $13.11 |
| Resistance Level | $30.90 | $16.65 |
| Average True Range (ATR) | 1.52 | 0.93 |
| MACD | -0.48 | -0.24 |
| Stochastic Oscillator | 5.82 | 13.13 |
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Exzeo Group Inc provides turnkey insurance technology and operations solutions to insurance carriers and their agents based on a proprietary platform of purpose-built software and data analytics applications that are specifically designed for the property and casualty, or P&C, insurance ecosystem. Its Insurance-as-a-Service (IaaS) platform, which it refers to as the Exzeo Platform, currently includes nine configurable software and data analytics applications that are purpose-built to serve insurance companies and other customers in the insurance value chain. Through the Exzeo Platform, the company provides technology-based solutions and services for all operational and administrative activities and functions needed by P&C insurance carriers and their agents.